BALYASNY ASSET MANAGEMENT L.P. – BioMarin Pharmaceutical Inc. Transaction History
BALYASNY ASSET MANAGEMENT L.P. portfolio value:
$66.61M
portfolio value
BALYASNY ASSET MANAGEMENT L.P. quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +39.15% | 221.09K shares | 19.81M | $84.77 | 785.78K |
| Q2 2022 | share | Increase | +2895.75% | 545.84K shares | 45.34M | $82.87 | 564.69K |
| Q1 2022 | share | Increase | 0.00% | 18.85K shares | 1.45M | $77.1 | 18.85K |
| Q2 2021 | share | Decrease | -100.00% | -19.65K shares | -1.48M | $83.44 | 0 |
| Q1 2021 | share | Decrease | -87.97% | -143.75K shares | -12.84M | $75.51 | 19.65K |
| Q1 2021 | call | Decrease | -100.00% | -53K shares | -4.64M | $75.51 | 0 |
| Q4 2020 | share | Increase | +346.70% | 126.82K shares | 11.54M | $87.69 | 163.40K |
| Q4 2020 | call | Increase | 0.00% | 53K shares | 4.64M | $87.69 | 53K |
| Q3 2020 | call | Decrease | -100.00% | -100K shares | -12.33M | $76.08 | 0 |
| Q3 2020 | share | Decrease | -65.76% | -70.24K shares | -10.39M | $76.08 | 36.58K |
| Q2 2020 | call | Increase | 0.00% | 100K shares | 12.33M | $123.34 | 100K |
| Q2 2020 | share | Decrease | -70.84% | -259.46K shares | -17.77M | $123.34 | 106.82K |
| Q1 2020 | share | Decrease | -41.34% | -258.12K shares | -21.84M | $84.5 | 366.29K |
| Q4 2019 | call | Decrease | -100.00% | -50K shares | -3.37M | $84.55 | 0 |
| Q4 2019 | share | Increase | +324.73% | 477.40K shares | 42.88M | $84.55 | 624.41K |
| Q3 2019 | share | Decrease | -63.95% | -260.75K shares | -25.01M | $67.4 | 147.01K |
| Q3 2019 | call | 0.00% | 0 shares | -1.02M | $67.4 | 50K | |
| Q2 2019 | call | Increase | 0.00% | 50K shares | 4.39M | $85.65 | 50K |
| Q2 2019 | share | Increase | +2750.71% | 393.46K shares | 33.65M | $85.65 | 407.76K |
| Q1 2019 | share | Decrease | -93.85% | -218.28K shares | -18.53M | $88.83 | 14.30K |
| Q4 2018 | share | Decrease | -55.51% | -290.22K shares | -30.89M | $85.15 | 232.59K |
| Q3 2018 | call | Decrease | -100.00% | -368.7K shares | -34.73M | $96.97 | 0 |
| Q3 2018 | share | Increase | +25.44% | 106.04K shares | 11.43M | $96.97 | 522.81K |
| Q2 2018 | share | Decrease | -59.86% | -621.52K shares | -44.91M | $94.2 | 416.77K |
| Q2 2018 | call | Increase | 0.00% | 368.7K shares | 34.73M | $94.2 | 368.7K |
| Q1 2018 | share | Decrease | -40.72% | -713.09K shares | -71.99M | $81.07 | 1.03M |
| Q4 2017 | share | Increase | +64.97% | 689.77K shares | 57.36M | $89.17 | 1.75M |
| Q3 2017 | share | Increase | +315.93% | 806.37K shares | 75.62M | $93.07 | 1.06M |
| Q2 2017 | share | Decrease | -57.13% | -340.17K shares | -29.08M | $90.82 | 255.24K |
| Q1 2017 | share | Increase | +32.18% | 144.94K shares | 14.94M | $87.78 | 595.41K |
| Q4 2016 | share | Decrease | -17.62% | -96.31K shares | -13.27M | $82.84 | 450.47K |
| Q3 2016 | share | Increase | +49.07% | 179.98K shares | 22.05M | $92.52 | 546.78K |
| Q2 2016 | share | Increase | +24.04% | 71.07K shares | 4.14M | $77.8 | 366.80K |
| Q1 2016 | share | Decrease | -37.72% | -179.13K shares | -25.35M | $82.48 | 295.72K |